Literature DB >> 29271303

Assessing alliance ruptures and resolutions: Reliability and validity of the Collaborative Interactions Scale-revised version.

Antonello Colli1, Daniela Gentile2, Valeria Condino1, Vittorio Lingiardi2.   

Abstract

OBJECTIVE: This study presents the revised version of the Collaborative Interactions Scale (CIS) [Colli, A., & Lingiardi, V. (2009). The Collaborative Interactions Scale: A new transcript-based method for the assessment of therapeutic alliance ruptures and resolutions in psychotherapy. Psychotherapy Research, 19(6), 718-734.], an observer-rated measure for the assessment of therapeutic-alliance ruptures and resolutions. Intensive use of the previous scale resulted in three criticisms: (i) excessive time required to perform evaluations, (ii) the low occurrence of some items, and (iii) the scale's low capacity to capture some patient-therapist interactions in fine detail. In this study, we aimed to describe the scale revision process and evaluate interrater reliability and scale validity by comparing sessions of patients with and without personality disorders (PDs).
METHOD: Three raters conducted a blind evaluation of a sample of 60 sessions (180 segments; 3607 narrative units) with 30 patients (15 had a PD diagnosis and 15 had a DSM-5 clinical syndrome diagnosis without a PD).
RESULTS: Interrater reliability results ranged from acceptable to excellent and were comparable to those of the former version. Patients with PDs showed a greater number of alliance ruptures and a smaller number of collaborative processes than patients without PDs. Moreover, therapists presented more negative interventions with the PD sample than with the non-PD sample.
CONCLUSIONS: The results indicate that the revised CIS is a reliable rating system that is useful for both empirical research and clinical assessments. Clinical or methodological significance of this article: The CIS-R is a reliable rating system that is suitable for both empirical research and clinical assessment. It is useful for recognizing rupture and resolution processes, both in clinical everyday practice and in psychotherapists' training. Application of the CIS-R promotes clinical reflection on the therapeutic action used to manage ruptures in a session.

Entities:  

Keywords:  Collaborative Interactions Scale; alliance ruptures and resolutions; personality disorders

Mesh:

Year:  2017        PMID: 29271303     DOI: 10.1080/10503307.2017.1414331

Source DB:  PubMed          Journal:  Psychother Res        ISSN: 1050-3307


  6 in total

1.  Rupture Resolution Rating System (3RS): Development and validation.

Authors:  Catherine F Eubanks; Jessica Lubitz; J Christopher Muran; Jeremy D Safran
Journal:  Psychother Res       Date:  2018-12-10

2.  The development of an observational coding scheme to assess transgender and nonbinary clients' reported minority stress experiences.

Authors:  Stephanie L Budge; Eileen Guo; Ezra Mauk; Elliot A Tebbe
Journal:  Psychotherapy (Chic)       Date:  2021-06

Review 3.  Future Challenges in Psychotherapy Research for Personality Disorders.

Authors:  Ueli Kramer; Catherine F Eubanks; Katja Bertsch; Sabine C Herpertz; Shelley McMain; Lars Mehlum; Babette Renneberg; Johannes Zimmermann
Journal:  Curr Psychiatry Rep       Date:  2022-10-13       Impact factor: 8.081

Review 4.  Using mobile brain/body imaging to advance research in arts, health, and related therapeutics.

Authors:  Juliet L King; Francisco J Parada
Journal:  Eur J Neurosci       Date:  2021-06-07       Impact factor: 3.698

Review 5.  Alliance Ruptures and Resolutions in Personality Disorders.

Authors:  Nathalie Schenk; Lukas Fürer; Ronan Zimmermann; Martin Steppan; Klaus Schmeck
Journal:  Curr Psychiatry Rep       Date:  2020-12-11       Impact factor: 5.285

6.  The Action of Verbal and Non-verbal Communication in the Therapeutic Alliance Construction: A Mixed Methods Approach to Assess the Initial Interactions With Depressed Patients.

Authors:  Luca Del Giacco; M Teresa Anguera; Silvia Salcuni
Journal:  Front Psychol       Date:  2020-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.